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Abstract 
Pain and function in patients with rheumatic disease and elbow arthroplasty; clinical and methodological 
aspects 
Background: About 20-50 % of patients with rheumatoid arthritis (RA) have elbow joint involvement, and total 
elbow arthroplasty is a treatment option if the joint destruction is severe. Loss of elbow function is considered to 
be more disabling than loss of shoulder or wrist function, since normal elbow function is required for 
positioning the hand. Outcome after total elbow surgery is often presented as range of motion (ROM). However, 
loss of elbow function may influence health related domains on impairment level as well as on activity and 
participation level. Thus, tests and instruments used for monitoring and evaluating the result of elbow 
arthroplasty ideally should reflect all these domains.   
Objectives: The first aim was to describe the level of pain and physical function in patients with elbow 
arthroplasty. Secondly, a concurrent comparison of the methodological properties of four frequently used 
clinical- and patient assessed instruments for elbow function was performed.  
Methods: As part of a routine postoperative follow-up examination 1-5 years after total elbow arthroplasty in 
patients operated at Diakonhjemmet Hospital, a protocol was developed for evaluating the properties of the 
Disabilities of Arm, Shoulder and Hand Questionnaire (Quick-DASH) (patient assessed), the American 
Shoulder and Elbow Surgeons Elbow assessment form (ASES) (combination of patient- and clinical assessed) 
and the Mayo Elbow Performance Score (MEPS) (clinical assessed). The patient assessed measure of upper 
extremity function (Quick-DASH) was considered as the "gold standard" for measuring elbow function. For 
comparison, all scales were transformed to 0-100, 100 best health. The single items of the Quick-DASH were 
examined for floor and ceiling effects (more than 15% lowest or highest score). Correlations between the 
different patient- and clinical assessed measures were examined by Pearson correlation coefficient (r), and the 
coefficient of determination was used to calculate shared variance between the different scores and the Quick-
DASH. The Quick-DASH was used as dependent variable in a multiple regression analysis.  
Results: Thirty-two patients, mean (min-max) age 68 (21-93), 75% female were included. The patients with 
elbow arthroplasty had low grip strength and a total arc of flexion/extension less than 100 °. They reported 
moderate level of pain (mean (SD) 77 (22)), while the mean (SD) upper arm function was 47 (20) for the Quick-
DASH. Further, the mean (SD) satisfaction score was 69 (25), with 56% of the patients rating their elbow 
function as good or very good. Single items of the Quick-DASH regarding grip force activities showed floor 
effects. Significant correlations with Quick-DASH were found for all measures (p<0.01), except for ROM (r= 
0.2, p=0.35). ROM explained 3% of the variance in the patient assessed function scores while grip strength 
explained 29%. In a multivariate regression model, grip strength contributed significantly (p= 0.03), while ROM 
did not contribute to the variation (p=0.81) in the Quick-DASH scores.  
Conclusion: Patients with elbow arthroplasty reported moderate level of pain and they were (fairly) satisfied 
with the elbow arthroplasty. However, clinical tests revealed low grip strength and limited range of movement. 
Thus, both clinical- and patient assessed measures are needed for optimal evaluation and management of 
patients with total elbow arthroplasty.   
 
 
 
 
 
Sammendrag 
Smerte og funksjon hos pasienter med revmatisk sykdom og albuprotese; kliniske og metodiske aspekter 
Bakgrunn: Omtrent 20-50 % av pasientene med revmatoid artritt (RA) har affeksjon av albuleddet. Total 
protese i albuen er et behandlingsalternativ når destruksjonen i leddet er av omfattende karakter. Tap av 
albufunksjon er antatt å være mer begrensende enn tap av funksjon i skulder eller håndledd, da funksjon i albuen 
er nødvendig for å kunne bruke hånden. Måling av leddbevegelighet (ROM) er metoden som i størst grad 
benyttes for å dokumentere resultatet av albuprotesekirurgi. Dette til tross for at tap av albuefunksjon påvirker 
kroppsstrukturer men også pasientens aktivitet og deltagelse. Kliniske tester og instrumenter som benyttes for å 
følge og evaluere resultater etter albu protesekirurgi bør derfor ideelt sett reflektere alle disse områdene. 
Hensikt: Beskrive smerte og fysisk funksjon hos pasienter med albueprotese, samt gjøre en samtidig 
sammenlikning av de metodiske egenskapene hos fire mye benyttede klinisk- og pasientrapporterte instrumenter 
for albufunksjon.  
Metode: Som del av en postoperativ rutinekontroll 1-5 år etter innsetting av albueprotese ved Diakonhjemmet 
sykehus, ble det utviklet en protokoll for å evaluere de metodiske egenskapene til the disabilities of Arm, 
Shoulder and Hand Questionnaire (Kvikk-DASH) (pasientrapportert), the American Shoulder and Elbow 
surgeons assessment form (ASES) (kombinasjon av pasientrapportering og kliniske evaluering) og The Mayo 
Elbow Performance Score (MEPS) (klinisk evaluering). I denne studien ble selv-evalueringsinstrumentet Kvikk-
DASH antatt å være gullstandard for å måle funksjon i albuen. For å kunne sammenlikne, ble alle skalaer 
omregnet til 0-100, hvor 100 er best helse. Enkeltspørsmålene i Kvikk-DASH ble undersøkt for tak- og 
gulveffekter. Korrelasjon mellom de ulike klinisk- og pasientrapporterte instrumentene ble undersøkt ved bruk 
av Pearson korrelasjonskoeffisient (r), og koeffisienten ble benyttet for å regne ut overensstemmelse mellom de 
ulike instrumentene og Kvikk-DASH. Kvikk-DASH ble benyttet som en avhengig variabel i en multippel 
regresjonsanalyse.  
Resultat: Trettito pasienter med gjennomsnittsalder (min-max) 68 (21-93) år, hvorav 75 % kvinner, ble 
inkludert. Pasientene viste lav gripestyrke og bevegeligheten i albuen (fleksjon/ekstensjon) var mindre enn 100 
°. De rapporterte moderate smerter (mean (SD) 77 (22)), arm funksjonen var 47 (20) målt med Quick-DASH. 
Den gjennomsnittlige (mean (SD)) tilfredshetsskåren var 69 (25) og 56 % av pasientene vurderte albufunksjonen 
som god eller veldig god. Enkeltspørsmål i Kvikk-DASH som omhandlet gripestyrke viste gulveffekt. 
Korrelasjon mellom de ulike instrumentene og Kvikk-DASH var alle signifikante (p<0.01), unntatt for ROM (r= 
0.2, p=0.35). ROM forklarte 3 % variasjon i den pasientrapporterte funksjonsskåren, gripestyrke forklarte 29 %. 
I en multippel regresjonsmodell hadde gripestyrke en signifikant betydning (p= 0.03), mens ROM ikke hadde 
betydning for variasjonen (p= 0.64) i Kvikk-DASH. 
Konklusjon: Pasienter med protese i albuen rapporterte moderate smerter og de var relativt tilfredse med 
albueprotesen på tross av at kliniske tester viste lav gripestyrke og redusert bevegelighet. Både kliniske og 
pasientrapporterte instrumenter er derfor nødvendig for å oppnå en optimal evaluering og oppfølging av 
pasienter med protese i albueleddet.  
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Acronyms and definitions 
Activities of daily living         ADL 
American shoulder and elbow surgeons       ASES 
Canadian Occupational Performance Measure      COPM 
Disease-modifying anti-rheumatic drugs       DMARDs 
Health related quality of life        HRQOL 
International classification of functioning       ICF 
Mayo elbow performance score        MEPS  
Medical Outcome 36-item Short Form Health Survey     SF-36 
Non-steroidal anti-inflammatory drugs       NSAIDs 
Occupational therapy/ occupational-therapist      OT 
Osteoarthritis          OA 
Patient rated elbow evaluation        PREE 
Physical therapy / physio-therapist       PT 
Range of motion          ROM 
Patient reported outcome measures       PROM 
Rheumatoid arthritis         RA 
Short version, the Disability of Arm, Shoulder and Hand     Quick-DASH  
Tissue necrotic factor blockers        TNF  
Total elbow arthroplasty         TEA 
Visual analogue scale         VAS  
World Health Organization        WHO 
 
Pain: "an unpleasant sensation and emotional experience with actual or potential tissue damage or described in 
terms of such damage" (The International Association for the Study of Pain, IASP, 1986) 
Function: physical functioning and disability (body functions and structures, activities and participation) 77 
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1. Introduction 
Rheumatoid arthritis (RA) is a chronic, inflammatory systemic disease affecting the 
connective tissue, mainly in the musculoskeletal system, but also in extra-articular organs. 
Joint swelling, tenderness, pain, decreased function and stiffness accompany fatigue in the 
unpredictable deterioration of the disease, which in the long run may cause joint destruction 
64. RA has a prevalence of 0.5-1.0 % in the adult population in most western countries and is 
the most frequent inflammatory rheumatic disease 43. Based on studies performed in western 
countries the prevalence of RA is higher in females compared to males 70. 
Eventually, 20-50 % of the patients show clinical and radiological evidence of elbow joint 
involvement 4;32. Elbow arthritis typically results in pain, stiffness and joint destruction. 
Elbow arthritis occurs most often in people with rheumatic diseases and, in some cases, with 
post-traumatic osteoarthritis after a traumatic incident, in most cases seen as a fracture of the 
supracondylus humeri. About 80 % of all elbow arthroplasties are operated secondary to RA 
or other rheumatic diseases 4. 
The associated symptoms of chronic synovitis of the elbow, i.e. pain, deformity, muscle 
weakness, instability and loss of motion and may finally result in significant disability. The 
treatment is usually directed to reduce pain, next to reduction of inflammation and functional 
improvement. Non-surgical management consists of oral analgesics, intra-articular steroid 
injections, physical therapy and splinting 26. However, when conservative treatment no 
longer provides relief, total elbow arthroplasty is considered as a treatment option in the 
prevention of permanent disability 51 30.  
Total elbow arthroplasty can provide satisfactory results in patients with significant 
destruction of the elbow, especially in RA. With the introduction of the semi constrained 
prostheses, the complication rates reduced from 45 % in the late 1970s to 11-20 % in the 
1990s 30 38 22 1. However, severity of the disease in terms of joint destruction as well as 
several patient-related factors such as age, activity level and expectations should be taken 
into account before deciding upon this type of surgery. Due to issues regarding infection, 
loosening and prosthesis survival, this procedure is generally avoided in young active 
patients 63.  
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Individuals with a rheumatic disease suffer from a chronic, degenerative and systemic 
disease. In contrast to the single joint affection mostly seen in patients with osteoarthritis, 
the degenerative progression in RA patients most certainly will affect many joints over time, 
often resulting in severe impact on health related quality of life 37. Because rheumatic 
diseases are often complex and affect many aspects of the patient's life, effective 
management requires the coordinated efforts of a diverse group of professionals. In addition 
to involvement in the contra lateral elbow, the adjacent shoulder and wrist joints are affected 
by the disease in up to 80 % and 90 % respectively 36. Any treatment must account for 
disabilities of other affected joints and it is therefore important to develop a treatment 
strategy for the entire extremity 26.  
To ensure the necessity of a total elbow arthroplasty, monitoring the disease course is 
important, in terms of assessing pain, strength, range of motion (ROM), physical function 
and daily activities over time. Studies providing results after elbow arthroplasty are mainly 
based on clinical assessed outcome measures on impairment level, most often presented as 
range of motion. Few have studied the elbow arthroplasty with standardized, valid and 
comprehensive instruments and methods (Table 2). For a long time, rating scales have often 
been used without formal testing of their measurement characteristics. Yet, in recent years 
increasing emphasis has been put on measurement theory in the evaluation of surgical 
orthopaedic treatments, and there is a broad consensus that outcome scales should be 
established and proven reliable and valid before they are used as an outcome measure 69 6 18 
39 2. Nevertheless, properly designed reliability and validity studies are still needed for the 
majority of commonly employed scores in orthopaedic surgery. There are multiple reports in 
the literature of the mid- and long-term results after elbow arthroplasty, but most of these are 
based on clinical assessed instruments; only few studies have employed standardized, valid 
instruments taking both the medical and the patient perspectives into account 4;34.  
A surgical intervention, like total elbow arthroplasty,  will probably influence patients' life in 
several areas. Ranging from impairment level, where the body-structures and -functions are 
measured to a more patient based perspective where the ability to perform various activities 
or participate in life situations are assessed. Over the last few years, the development of 
clinical outcome tools have shown that standardized, well tested instruments can give a valid 
and reliable reflection of the patient's health status and health related quality of life 
(HRQOL) in different health disorders and across different settings. This is particularly so 
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when taking the patient based perspective into account. In addition to assessing the direct 
impact of the disease on specific joint function, patient-based instruments allow the 
assessment of global functional capacity during the performance of everyday activities and 
of the patient's ability to participate in social activities.  
1.1 Aims of the study 
In a cross sectional follow-up examination 1-5 years after total elbow arthroplasty in patients 
operated at Diakonhjemmet Hospital, several frequently used methods and instruments for 
measuring elbow function were applied concurrently. The aims of this comprehensive 
examination was to describe the level of pain and function in patients with elbow 
arthroplasty, and to evaluate psychometric properties of some clinical- and patient assessed 
instruments for evaluation of elbow function after total elbow arthroplasty.  
1.2 A priori hypothesis  
1. Patients operated with elbow arthroplasty within the last 5 years experience moderate 
level of pain and have good function 
2. The commonly used elbow instruments are appropriate for evaluating elbow function 
in patients with total elbow arthroplasty 
3.  The patient assessed instrument for evaluating total arm function, the Quick-DASH,  
can be considered as a gold standard for assessing elbow function 
4. Clinical assessed outcome measures, such as range of motion and grip-force agree 
with the patient assessed function 
5. The instruments can distinguish between patients reporting to have good elbow 
function and those who report to have moderate/ bad elbow function  
6. Range of motion is frequently used for evaluating total elbow arthroplasty, thus 
satisfactory inter-rater reliability is expected  
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2. Background 
2.1 The elbow joint 
Three bones, the humerus, radius and ulna form the elbow joint. Articulations between the 
trochlea of the humerus with the ulna and the capitulum of the humerus with the head of the 
radius comprise the joint. The elbow is an example of a hinge joint, or a joint that moves in 
only one direction 63 75. Two main movements are possible at the elbow. The hinge-like 
bending and straightening of the elbow (flexion and extension) take place? at the articulation 
between the humerus and the ulna. The complex action of turning the forearm over 
(pronation and supination) happens at the articulation between the radius and the ulna (this 
movement also occurs at the wrist joint). In the anatomical position (with the forearm 
supine), the radius and ulna lie parallel to each other. During pronation, the ulna remains 
fixed, and the radius rolls around it at both the wrist and the elbow joints. In the prone 
position, the radius and ulna appear crossed. Most of the force through the elbow joint is 
transferred between the humerus and the ulna. Very little force is transmitted between the 
humerus and the radius 75.  
Normal passive elbow motion has been reported to range between 0 ° extension and 140 ° to 
150 ° flexion. Greater variation of normal forearm rotation has been described, but averages 
about 75 ° pronation and 85 ° supination 49;52;54. The functional ROM of the elbow has been 
shown to be 30 ° of extension to 130 ° of flexion and 50 ° of pronation to 50 ° of supination 
52.  
A functional elbow must have a total flexion-extension arc of 100 °. What is of particular 
importance, however, is the amount of motion used for daily activities and what each 
individual needs in their functional setting. To fulfill optimal function the elbow must be 
free from pain, mobile and stable 58.  
Elbow function can be described as three activities: 1) to allow the hand to be positioned in 
space, 2) to provide the power to perform lifting activities and 3) to stabilize the upper 
extremity linkage for power and fine work activities. One may consider essential 
components of joint function as range of motion, strength, and stability. However, the final 
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determinant of function is ultimately determined by pain and the ability to perform activities 
of daily living 52.   
 
Figure 1: Bony anatomy of the elbow joint  
2.2 Elbow Arthritis 
Arthritis literally means joint inflammation and is not a single disease. Arthritis refers to a 
ted 
l 
2.2.1 Prevalence of elbow arthritis 
Unlike the hip, knee, and shoulder joints the elbow deteriorates as a result of primary 
w 
A, 
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group of more than 100 rheumatic diseases and other conditions that can cause pain, 
stiffness and swelling in the joints. The three most common types of arthritis are RA, 
posttraumatic arthritis and primary osteoarthritis. The most common complaint associa
with elbow arthritis is pain, along with reduced range of motion. Age and overall functiona
status of the patient are important factors to consider when formulating a treatment plan.  In 
arthritis of the elbow, the cartilage of the joint is reduced or lost 63.  
osteoarthritis in only 1 to 2 % of the cases of elbow arthritis 26. About 80 % of all elbo
arthroplasties are operated secondary to RA 4. The elbow joint is frequently involved in R
eventually 20-50 % of the patients show clinical and radiological evidence of elbow joint 
involvement 18. According to some scientific literature up to 50 % of patients with RA will
present with elbow arthritis 63 32. There has been found evidence of 53 % elbow involvemen
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in a series of 300 patients with 10 years' average duration of RA 30. In a 15 years follow-up 
of 148 elbows (74 patients with RA) the conclusion after 15 years was that more two of 
three patients with RA had elbow arthritis. This was mostly severe destructions and most
often bilateral affection 
 
2.2.2 Rheumatoid Arthritis 
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2.2.3 Posttraumatic Osteoarthritis 
atic insult to the elbow, regardless of 
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46.  
atoid Arthritis (RA) is a comm
% of the population and up to 3 % of the population over the age of 65 years. It appears 
twice as often in women, and the age onset is mainly between 45 and 65 years. The clinic
picture of RA is characterized by pain, fatigue, disability and reduced quality of life. The 
course of the disease is often unpredictable, and the symptoms may vary 64. The disease is
immune-mediated process that affects the synovial and lines appendicular joints as well as 
the atlanto-axial joint of the cervical spine. It is associated with marked disability and 
decreased life expectancy. Patients can present with extra skeletal manifestations, such
anemia, pulmonary conditions, cardiac disease, and vasculitis. A thorough history and 
physical examination are essential when treating these patients. Patients with RA of the
elbow usually complain of pain through the arc of motion 16. The ulnotrochlear articulati
is generally affected first although patients may display limitation in the forearm rotation as 
the disease process becomes advanced. Instability may also play a role in the elbow 
dysfunction. The loss of bony congruency, with or without destruction of soft tissue 
stabilizers, can often result in severe and symptomatic instability 63.  
Posttraumatic Osteoarthritis may occur after any traum
severity. It can occur in patients of either gender and of any age, but is most common in 
young males 51. The risk of developing this condition correlates with both the injury patte
and the energy of the injury. Intra- articular distal humerus fractures, for example, are most 
often associated with the development of degenerative joint disease over time 58. Similar to 
patients with RA, patients who suffer from posttraumatic osteoarthritis will complain of pain
throughout the arc of elbow motion. In contrast, as a result of both articular incongruity as 
well as soft tissue contracture, instability is rarely a concern 63.  
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2.2.4 Primary Osteoarthritis  
Primary Osteoarthritis (OA) of the elbow is a disease that is almost exclusive to males, and 
has a strong association with strenuous use of the arm in activities ranging from weight 
lifting to operating heavy machinery. It is a relatively rare disease, affecting <2 ° of the 
population 15. In 1936, Rostock 63 reported a nearly 33 % incidence of primary OA in a large 
population of coal miners. Unlike OA of other joints, OA of the elbow is characterized by 
the relative preservation of articular cartilage and the maintenance of joint space, but with 
hypertrophic osteophyte formation and capsular contracture.  The pattern of pain in patients 
with primary OA is quite different than that of patients with RA. OA patients classically 
complain of impingement pain at the extremes of motion, most notably in extension. During 
the early course of the disease, when the joint space is still maintained, osteophytes in the 
olecranon fossa and the proximal portion of the olecranon cause pain in the maximal 
extension. Similarly, if osteophytes formation occurs in the trochlea or in the coronoid 
process, impingement pain may be noted in extreme flexion. Patients may complain of pain 
throughout the arc of motion, but this is typically a late finding when the disease is more 
advanced 63 15.  
2.2.5 Signs and symptoms of elbow arthritis 
The complaints of patients who present with elbow arthritis will vary, depending on the 
specific arthritic condition from which they suffer. The clinical presentation of the patient 
with RA of the elbow depends on the stage of the disease. Complaints of pain and limited 
ROM, however, are common to all stages of the disease. It is well known that grip strength 
is profoundly affected in RA patients 9;10;68, and strength is directly influenced with pain, 
producing a reflex inhibition of strength 53. Early on, synovitis is a prominent feature. 
Patients present with a warm, swollen elbow and painful limitation of the flexion- extension 
arc and the pronation-supination arc. A mild flexion contracture is to be expected. As the 
disease progress, the clinical features of synovitis become less prominent, and the painful 
limitations of elbow motion results from joint destruction and articular incongruity. The 
pain, now more mechanical in nature, occurs throughout the arc of motion. Loss of extension 
and resultant contracture develop rapidly 56. With progressive bone loss and soft tissue 
compromise, up to 25 % of patients complain of instability 50 3. 
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2.3 Conservative treatment 
Nonoperative management of elbow arthritis is similar to that of other arthritic joints. If not 
medically contra-indicated, patients should be prescribed analgesics, such as non-steroidal 
anti-inflammatory drugs (NSAIDs) for pain control. Many classes of drugs exist that can aid 
in the medical management of RA, including oral steroids, disease-modifying anti-rheumatic 
drugs (DMARDs), and tissue necrotic factor (TNF) blockers 76. Intra-articular steroid 
injections can be very effective in the management of acute rheumatoid flares and have also 
been successful as maintenance therapy in patients with degenerative joint disease 63. 
Elbow pain and stiffness can dramatically impair functional use of the upper extremity. 
Physical therapy is therefore important for optimizing general function in the adjacent joints 
and for the maintenance of mobility and strength. The maintenance of a functional arc of 
elbow motion (100 °) assures that the hand can be placed within a functional space for 
activities of daily living 58. Heat- and cold therapy and gentle exercises may sometimes be 
useful for minimizing pain, but the evidence for such treatment is not clear.  
Another important factor can be a joint protection program, which instructs the patient in 
techniques to perform activities of daily living with reduced joint reactive forces. This 
approach serves to reduce pain, minimize further joint deterioration, and conserve energy. 
Some of the basic techniques are to avoid aggravating activities, to respect pain and use it to 
guide physical activity, to avoid deforming positions, and to strike a balance between use of 
the elbow and rest. Hinged braces can serve to protect the elbow from stresses on the coronal 
plane while still permitting active range of motion. Night splints act to both rest, protect and 
to avoid contracture of the elbow during sleeping hours. For maximal benefit, most patients 
are advised to utilize all or some combination of these modalities and other assistive devices 
58 56 63..  
When non-operative modalities fail and surgical intervention is indicated, the type and 
severity of arthritis, as well as the age and activity level of the patient, will strongly 
influence the type of surgery best suited for the patient: open versus arthroscopic 
debridement, radial head excision, interpositional arthroplasty, total elbow arthroplasty 
(TEA), or arthrodeses 26 63 50.  
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2.4 Total elbow joint arthroplasty 
2.4.1 Historical perspective 
Elbow arthroplasty was developed in the middle of the 20th century, and for the first 20 
years of its existence, it consisted largely of hemi-arthroplasty resurfacing of the humerus or 
ulna or both and were characterized by two relatively short stems with a highly constrained 
hinge that only permitted motion in the flexion/ extension plane. These implants were 
plagued by instability, loosening, and recurrent pain and overall poor function and the desire 
for varus/ valgus movement brought about the concept of hinge laxity. In 1972, Dee 
introduced the first cemented total elbow arthroplasty, which has had several modifications 
66.  Many companies have followed since and they achieved good clinical outcomes with 
these replacements, but the rates of loosening were very high; up to 27 % after 3 years 71. 
This disadvantage was probably caused by strong forces at the bone cement interface arising 
from the hinged articulation of the prosthesis. New developments were made, resulting in 
semi-constrained prostheses which more closely resemble normal elbow mechanics, 
reducing stress on the implant and the articulating surfaces. Finally, the non-constrained 
(resurfacing) types were developed, in which the humeral and ulnar components are not 
fixed together, but the collateral ligaments and annular ligament achieve the stability. For the 
last decade the semi- constrained and non-constrained types of the TEA have been, by far, 
mostly used 66 50 47 26.  
2.4.2 The total elbow arthroplasty 
There are many different prosthesis designs to choose between when performing a total 
elbow arthroplasty (TEA). The different designs are generally grouped as constrained, semi- 
constrained, and non-constrained. There is little consensus as to the best implant to use in 
different clinical settings 47 71.  
Constrained implants confer coronal stability by limiting motion to flexion and extension, 
but they have fallen out of favour because these prostheses caused increase stress on the 
bone-cement interface and led to high rates of loosening. Non-constrained implants are the 
most anatomic and bone preserving. These systems, however, transmit more force through 
the adjacent soft tissues and therefore require inherent elbow stability, which is often lacking 
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in rheumatoid and posttraumatic end-stage arthritis elbows. The most common type of elbow 
replacement is semi-constrained prosthesis. Semi-constrained replacement allow 8 ° to 10 ° 
of varus/ valgus motion; this limited amount of constraint appears to offer adequate stability 
without overloading the bone-cement interface 26.  
The Discovery Elbow System (Biomet Orthopaedics) is one of the latest generations of 
elbow replacement systems and is at the moment the system mostly used by orthopaedic 
surgeons at Diakonhjemmet hospital. It's minimally (semi-) constrained design provides 
more closely matching articular surfaces, avoids use of true hinge, and anatomically 
reproduces the axis of elbow motion. The Discovery Elbow System incorporates humeral 
and ulnar stems that closely match the anatomy of the medullary canals to correctly position 
and more anatomically reproduce hinge mechanics and axis of motion 33. Important points of 
attention performed during the surgical procedure is decompression of the ulnar nerve for 
protection, the triceps is in most cases reflected off of the ulna and later repaired with sutures 
(pooley technique), the ulnar collateral ligaments is, if possible, preserved and the radial 
head is very often resected to avoid limitation in forearm rotation and continued pain, 
especially if the proximal radioulnar joint is arthritic (ibid).  
 
 
 
 
The drawings is reproduced with permisson from Biomet Orthopedics, Inc.  
Figure 2: The Discovery total elbow prosthesis  
2.4.3 Indications and contraindications  
Total elbow arthroplasty (TEA) is considered for those who have moderate to severe elbow 
arthritis that causes considerable pain, limitation of motion and functional deficit and who 
have failed nonsurgical treatment and the less invasive surgery. Due to concomitant disease 
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in the ipsilateral extremities, rheumatoid patients are expected to have decreased functional 
requirements and stress the implant less than others; therefore, any patient older than 30 
years with gravely elbow arthritis and failed nonsurgical and less invasive surgical treatment 
might be a candidate for elbow replacement 26;32. Although an unconstrained prosthesis can 
be considered for the stable rheumatoid elbow without notable bone erosion, semi-
constrained, cemented implants are preferred in the majority of cases due to the high 
incidence of instability. Patients with primary osteoarthritis or posttraumatic arthritis of the 
elbow generally load the implant more vigorously and consequently can experience 
accelerated wear and loosening. The consensus minimum age is therefore advised to be 60 
years (ibid). It is important to be aware of the patient's functional limitations and extent of 
polyarticular involvement before a total elbow surgery is performed. In cases of which the 
lower extremity is equally involved, consideration is given to reconstructing the lower 
extremity first in an attempt to avoid excessive stress being placed on the upper extremity 
implants through the use of aids 50. Hand and wrist reconstruction is given precedence over 
TEA. In cases of equal involvement of the ipsilateral elbow and shoulder, the elbow 
generally takes preference over the shoulder. In one clinical study, greater functional return 
and a longer interval between replacements was observed when the elbow was operated on 
first 24. The exception to this is when the shoulder is ankylosed. Then consideration is given 
to shoulder replacement first to reduce increased rotational stresses that might be placed on 
the elbow replacement as the result of absent shoulder motion. One study have found that 
when there is severe arthritis of both the shoulder and the elbow, consideration should be 
given to replacing both joints in order to obtain optimal functional and clinical outcomes 29.  
Several contraindications exist and should be carefully considered to avoid complications 30. 
First, active infection and, to a lesser extent, any previous infection of the elbow joint 
preclude insertion of a total elbow prosthesis. Second, skin marked by multiple scars or 
adherent to bone might not provide a suitable soft- tissue envelope to support an underlying 
implant. Third, poorly motivated patients or those with palsy of the flexor or extensor 
muscles might never attain enough function to make the extensive procedure worthwhile. 
Finally, patients are informed preoperatively that the elbow replacement will not hold up to 
excessive physical loads. Activity limitations are discussed and patients are advised on a 
lifetime limit to avoid lifting objects greater than 2.5 to 5 kg in order to prevent early implant 
failure 63. Due to these activity restrictions, TEA is best performed in low-demand patients. 
Implant survivorship is better in low-demand patients functionally compromised by 
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rheumatic disease than in posttraumatic or osteoarthritis patients who otherwise are active 
and have no significant disabilities other than their elbows. Older age is described as a useful 
guideline for deciding upon employment of elbow replacement. In our current society, an 
increasing number of patients are maintaining physically active lifestyles, playing activities 
such as golf into their seventies and eighties. The decision to proceed with elbow 
replacement should be made considering both age and activity level 33.  
2.4.4 Adverse effects of total elbow arthroplasty 
There are numerous potential complications associated with total elbow arthroplasty. The 
most common is wound breakdown, and others include ulnar nerve irritation, deep infection, 
aseptic loosening, triceps deficiency, peri-prosthetic fracture, joint instability and implant 
failure. Wound complication after TEA may occur in up to 6 % of cases. The reported rate of 
deep infection of total elbow implants varies from 1 % to 13 % 38.  
Aseptic loosening is a late complication of TEA and is usually separated into radiological 
loosening and clinical loosening. The rate of radiological loosening in an otherwise 
asymptomatic patient may be as high as 17 %, while the rate of clinical loosening is 
significantly lower (6 %) 63. 
2.4.5  Rehabilitation after total elbow arthroplasty 
Few of the studies regarding elbow arthroplasty discuss the use of physical therapy (PT) or 
occupational therapy (OT) after TEA explicit, and some papers even state that PT and OT is 
not  required after total elbow arthroplasty 47;50. However, postoperative follow up by 
physiotherapist and occupational therapist is common in the clinical practice. One important 
factor is communication between the surgeon and the therapist to assure appropriate follow 
up since there are several factors that will affect postoperative management. The main 
factors that affect rehabilitation include the type of implant used, the management of the 
triceps tendon, the overall stability assessed in the operating room and the status of the ulnar 
nerve. Patient goals and activity level also play a role in determining therapy guidelines and 
expectations after total elbow arthroplasty. Despite stringent guidelines for patient selection, 
there is still a variance in patient goals and expectations for range of motion, strength, and 
desired activity level following surgery. While all patients must be educated regarding the 
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limitations of the prosthesis, the patients with more active lifestyles often have to be 
reminded of these restrictions. They usually require slightly longer periods of protective 
splinting to prevent overuse. More active patients often tend to have increased expectations 
for range of motion and these patients tend to remain in therapy longer for passive stretching 
and static progressive splinting programs because of these increased expectations.  
One of the major goals of TEA is to reduce pain and to restore motion of the joint. Once 
sufficient healing has occurred and the inflammatory phase of healing has passed gentle 
passive stretching can be performed. Further treatment is hands-on in terms of reducing 
edema and instruction in active exercise programs. Fabrication of splints is often done by the 
occupational therapist. Later on, once the elbow is comfortable and flexible, strengthening 
exercises and additional activities are started 66 27. 
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3. Methodological theory 
3.1 Outcome measures 
3.1.1 The development of outcome measures  
A health outcome measure has been described as a measure of health change, at a defined 
point in time, as a result of one or more health care processes 74. The measurement of 
outcome has become increasingly widespread over the past two decades in response to move 
beyond more “appearance of benefit” as an indicator of therapeutic impact. The tools 
derived for this purpose are usually referred to as health outcome measures. The 
implementation, interpretation and evaluation of outcome measures have caused much 
debate and controversy over the years within the health literature. Historically, Florence 
Nightingale was one of the first to look critically at outcome. She concluded that regimental 
mortality in the Crimean war was inversely proportional to the distance from the hospital. 
From this she devised a system for comparing death rated by diagnostic category and went 
on to introduce the daily "outcome synopsis of: relived/ unrelieved/ died". This was in use 
until the 1960s. Another pioneer was E.A. Codman from the Massachusetts General 
Hospital. In 1910, he suggested a one-year recall on all patients treated to see if their 
treatment had achieved the initial objective. His classic paper on "the Product of a Hospital" 
(Codman, 1914) asked if this unclear question could be measured, perhaps in terms of: 
"healthy babies delivered, faithful nurses trained, promising young surgeons and 
physicians". He concluded with a question that is still central in clinical practice today- 
"what happens to the patient?" 23. 
Two of the most dominant frameworks suggested for the measurement of health outcomes 
are; the International Classification of Functioning (ICF) and Health Related Quality of Life 
(HRQOL) 77. 
The first conceptual framework, the ICF, formerly known as the International Classification 
of Impairment, Disability and Handicap (ICIDH), is a comprehensive conceptual framework 
of outcomes in the measurement of health 77. The ICF assigns the term “functioning” as 
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encompassing the positive components of health, and “disability” as encompassing the 
negative components of health. Disability is further subdivided into impairments, activity 
limitations and participation restrictions within the context of environmental facilitators and 
barriers (ibid).  
 
The second conceptual framework for the measurement of health outcomes is HRQOL. 
Although the precise definition of HRQOL is debated, there is agreement that HRQOL 
measures include multiple dimensions and that they are important to the individual and 
relevant to the particular health intervention 59. HRQOL is purported to include dimensions 
that describe a persons physical, social and psychological health 59 12;65. Even if the 
definition is neither precise nor agreed, quality of life research seeks two kinds of 
information, the functional status of the individual and the patient's appraisal of health as it 
affects his or her quality of life 55. 
In the last decades instruments for assessing function have had three main goals: to describe 
present function, to measure change over time and/or to predict function in the future. The 
different measures can be classified by the way they are constructed and developed in 
relation to what they measure. Outcome measures are often divided as either objective or 
subjective instruments. The objective instruments are developed based on the medical 
perspective, with focus on dividing sick from healthy and to grade deviation from what is 
believed to be a normal function. The assessment is performed by the use of medical 
technical equipment, e.g. goniometer to measure range of motion. The objective way to 
measure function have in common that it can be used for all patients, since it demands very 
little participation from the patient, except from following instructions 42.  
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Medical perspective            Combined perspective                 Patient perspective 
 
Objective    Subjective 
 
From the 1980's patients became to a larger extent involved in self-assessing their function. 
At the same time activity related perspectives became extended to also include work, social- 
and leisure activities 25. Improved computer technology facilitated the opportunity to analyse 
huge datasets, and a number of questionnaires was developed and taken into account. One 
example is the Medical Outcome 36-item Short Form Health Survey (SF-36), which is a 
generic instrument used to assess function and HRQOL in a large group of patients 73. 
Another example is the Disability of Arm, Shoulder and Hand (DASH/Quick-DASH) 
questionnaire which is a more site specific instrument, focusing on the functional status and 
symptoms of upper extremity as one functional unit 7;8. 
Throughout the 1990's the patient perspective became more important. As a result of this, 
new dimensions of more patient perspective instruments were developed. In these 
instruments the patients were asked thorough interviews to describe and give preference to 
activities and goals, and then evaluate their own function and progression in relation to the 
priorities made 20. One example of such an instrument is the Canadian Occupational 
Performance Measure (COPM) 13.  
Generalisability          Individuality 
Low patient involvement                                                           High patient involvement 
 
 
   Continuum
Figure 3: Measures of function, categorised according to construction and degree of patient 
involvement 42 
Item generation 
performed by health 
professionals, 
assessment done by 
patients (e.g. Quick-
DASH) 
Item generation and 
assessment performed by 
health professionals (e.g. 
ROM) 
Item generation and 
assessment carried out by 
patients (e.g. COPM) 
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Over the past several years, the concepts of outcome research and assessment have become 
of increasing interest to clinicians, their patients and anyone who holds a stake in health 
care. A view of disease as a strictly biological phenomenon is no longer adequate; 
psychosocial consequences and functional impact are most relevant to patients and are key 
components in an assessment of the effect of disease or injury on health. The experience of 
health related challenges are often related to the patient's experience of the degree of pain, 
functional disabilities and quality of life (HRQOL). The complete assessment of the benefits 
of an intervention must therefore include evidence of the effect on the patient’s health status 
and HRQOL. Such evidence is usually based on self administered or interview administered 
questionnaires, which are increasingly referred to as patient reported outcome measures 
(PROM) 23. 
Two broad types of PROM exist; those that are specific to a site, disease or population and 
those that are generic and can be applied across populations, regardless of any underlying 
health problems 28. By PROM it means questionnaires or related forms of assessment that 
patients complete by themselves or, when necessary, others on their behalf complete, in 
order that evidence is obtained of their experiences and concerns in relation to health status, 
health related quality of life (HRQOL) and the results of treatment 23. Disease-, site- and 
population specific instruments have been developed in order to provide the patient's 
perception of a specific disease, health problem or in a certain population. The advantage is 
that the content is intended to be highly relevant, all of the items in the instrument should 
have been developed specifically to assess the particular population, site or health problem 
being studied 61.  
3.1.2 Outcome measures and total elbow arthroplasty 
Evaluation of total elbow arthroplasty requires outcome measurements that have the ability 
to clinically assess the direct impact on the specific joint function, but also patient 
assessments of global functional capacity during the performance of everyday activities and 
of the patient's ability to participate in social activities. Functional ability is considered as a 
clinical tool for measuring outcome, but one cannot only rely on measures on impairment 
level; the degree of degenerative changes on radiographs, or on generic measures of health 
status. Measurement of outcome after total elbow arthroplasty has tended to rely on non-
standardized scales and mostly on isolated impairment measures. Range of motion (ROM) is 
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the measure most widely used, despite the fact that clinical assessed measures of elbow 
function do not necessarily reflect patient well being, performance in ADL and HRQOL, and 
vice versa 69.  
The reporting of clinical outcomes after a total elbow arthroplasty has not fully evolved to 
routinely incorporate standardized outcome measures 48. This is true for both objective- and 
clinical assessed measurements like strength and ROM and for more subjective- and patient 
assessed ratings of pain, activity limitations and social participation. Several clinicians and 
researcher have designed their own elbow rating scales, and there exist a number of different 
scoring systems and measures that are used and developed for evaluating the elbow joint, but 
a consensus on which information is most important and which is the most valid method in 
relation to elbow arthroplasty and rheumatic diseases has not fully been reached. 
Nevertheless, there have recently been reported some recommendations to which outcome 
measures preferable to include in a core set. The SF-36 is a patient-assessed generic HRQOL 
questionnaire assessing physical, mental and bio psychosocial health in a holistic manner 73. 
The SF-36 has been used all over the world and has shown to have excellent psychometric 
properties and is responsive to change in patients with rheumatic diseases. SF-36 is proposed 
to be a part of a core set for assessing patients with total elbow arthroplasty 4 62. The Patient-
rated Elbow Evaluation (PREE) is also recommended, especially if a short set is preferable 
48 62. The PREE is a short patient-assessed questionnaire, four items assess pain intensity, 
one item assesses pain frequency and fifteen items assess disability. PREE is shown to 
correlate highly with the DASH 48. Another recommended measure to include is the 
American Shoulder and Elbow Surgeons (ASES) 41, this instrument is included in this study 
and will be accounted for in chapter 4.2. The Mayo Elbow Performance Score (MEPS) 52 is 
a widely used outcome measure for this group of patients, but were excluded in the 
recommendations explained by the fact that all the items are covered by the DASH or the 
PREE (Angst et al. 73-82). One study also found that DASH and ASES perform a better 
assessment of pain and function than MEPS 69. The MEPS and the Quick-DASH are 
explored in this study and will be explained further in chapter 4.2.  
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3.2 Psychometric properties of outcome measures 
Psychometric properties are the elements that contribute to the statistical adequacy of an 
instrument, assuring that the instrument consistently measure the constructs that it was 
intended to measure. There are many different elements indicating whether or not 
instruments provide good psychometric properties, but the focus in this paper is on the 
validity, internal consistency and inter-rater reliability of the instruments explored 23 19. 
3.2.1 Validity  
The validity of a measure is an assessment of the extent to which it measures what it is 
purported to measure. There are a number of different ways of establishing the validity of a 
measure. It is not a fixed property, but assessed in relation to a specific purpose or setting. It 
is therefore meaningless to refer to a validated measure; it should be considered a measure 
validated for use in relation to a specific purpose or set of purposes 23. For example, a valid 
measure for assessing patients after a total elbow arthroplasty cannot automatically be 
considered valid for use for assessing patients after a total elbow arthroplasty. There are 
different types of validity. Face and content validity are related, but while face validity 
refers to what an item appears to measure based on its manifest content. Content validity 
refers to how well a measurement battery covers important parts of the health components to 
be measured. Together, they address whether items clearly address the intended subject 
matter and whether the range of aspects is adequately covered. Construct validity is a more 
quantitative form of assessing the validity of an instrument. Construct validity shows how 
well the instrument measures the theoretical construct that it was designed to measure 23 19. 
Construct validity is explored by examining relationships of construct to a set of other 
variables, expressed with correlations 60. Concurrent validity is demonstrated where a test 
correlates well with a measure that has previously been validated. The two measures may be 
for the same construct, or for different, but presumably related, constructs. Concurrent 
validity is comparing a "new" tool or procedure with a gold standard. Criterion validity is 
used to demonstrate the accuracy of a measure or procedure by comparing it with another 
measure or procedure which has been demonstrated to be valid. Known-group validity 
determines whether or not the test or instrument has the capacity to distinguish between 
groups 23 19. The general concept behind known group validity testing is that a group of 
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individuals who are known to possess e.g., better function, score higher on a valid test than 
groups of individuals who are expected to have less function.   
3.2.2 Reliability  
Reliability is concerned with the reproducibility and internal consistency of a measuring 
instrument. If a measurement is free of random error, it is considered a reliable measurement 
with a true score of measure 23. Internal consistency of an instrument is often measured by 
using Cronbach’s alpha. All the individual items in an instrument should highly correlate 
with each other and with the summed score of the total of items in the same scale. All items 
need to be homogeneous, that is all measuring aspects of a single attribute rather than 
different constructs in order to have a good internal consistency.  Inter-rater reliability is 
determined when two or more raters judge the performance of one group of subjects at the 
approximately same point in time 19 8;23. If the score of the different raters is the same the 
test is believed to be of high or good inter-rater reliability. Description on how to perform 
and grade the test needs to be precise for a test to achieve a high or good inter-rater 
reliability (ibid).  
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4. Material and methods 
4.1 Design, subjects and criteria for inclusion 
This study has a non-experimental, cross sectional design. The patients were examined as 
part of a routine postoperative examination of patients with total elbow arthroplasty operated 
at Diakonhjemmet hospital during the last 5 years. A comprehensive examination was 
standardised by means of patient assessed instruments and a clinical examination. The 
clinical examination was performed subsequently by a surgeon and a physiotherapist, 
measuring strength, stability and range of motion of the elbow (Appendix I- IIII). (For 
convenience, a total of two surgeons and two physiotherapists were involved in the 
examinations).  
32 patients met to the follow-up examination. They were all 18 years or older with uni- or 
bilateral primary or revision elbow arthroplasty. All patients met for follow-up at one point, 
independent of time since last surgery. Patients were excluded if they had a malignant 
disease, alcoholism, serious mental problems or cognitive impairment.  
4.2 Instruments 
The selection of instruments was based on those that were currently used in clinical practice 
or instruments that were described in the scientific literature to be either much dealt with or 
valid and clinically well tested for the upper extremity. The instruments explored in this 
study are the Disabilities of Arm, Shoulder and Hand Questionnaire, the short version 
Quick-DASH (Quick-DASH) 8 31, the Mayo Elbow Performance Score (MEPS) 52 and the 
American Shoulder and Elbow Surgeons (ASES) 41. The methods consist of range of motion, 
pain, strength, stability, physical function, activities of daily living and impacts on social 
life. The measures contain patient- and/or clinical assessed instruments. The different 
conceptual frameworks of the measures explored, by means of ICF and HRQOL is 
illustrated in table 1.  
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The Quick-DASH is an 11- item score (short version of the DASH) that addresses disability 
of the upper extremity for all joints on both sides simultaneously. It has been validated and 
can be used for a variety of upper extremity conditions, but it tends to rate function more 
heavily than other measures used, as only two items ask about pain in the upper extremity 
7;8;31;35. Quick-DASH gives an overview of symptoms and function of both arms, but it has 
been reported that it can lead to problems in patients with multiple joints affected, e.g. 
patients with rheumatoid arthritis 21. It has not been validated for patients with a total elbow 
arthroplasty (Appendix I). | 
The MEPS have enjoyed widespread use (Table 2). It is primarily a clinical assessed 
instrument and contains assessment of pain, range of motion, stability and function on a total 
scale that rate 100 as the best score. 45 of the total 100 points are referred to pain in the 
elbow. MEPS contain clinical- and functional assessment completed by the clinician on the 
patient's behalf. Regrettably, there is a lack of standard terminology and information about 
how each item should be rated. The response items are not graduated, but just "present/ 
absent" options, and is therefore less able to discriminate between different grades of 
functional disability 52 (Appendix II).  
The third outcome measure explored in this study is the ASES, which comprise of 2 parts, a 
patient- and a clinical assessed part. The patient assessed part consists of 5 items asking 
about pain on a 5 point categorical scale (5 equals worst possible pain) and 10 items 
concerning functional ability for both sides separately on a 4 point categorical scale ranging 
from 0 to 3, 3 equals not difficult to perform. One item concerns satisfaction with the 
arthroplasty on a 10 point categorical scale, ranging from 1 to 10, 10 equals very satisfied. 
The clinical assessed part consists of ROM, stability, strength, grip-strength and signs and 
symptoms. Weighting of the various subscales and the computations of a sum scale 
methodologically have not been reported for the ASES 48. However, based on the concepts 
measured, the items were summarised in three subscales; function, pain and satisfaction. The 
different scales were analyzed separately.  In other studies the ASES has been split into one 
clinical and one patient assessed part 4 and analyzed separately. Grippit were used to 
measure grip strength. Grippit measures both the maximum momentary force and the mean 
force over a set period of time (10 seconds). The instrument consists of a grip device, an 
electronic unit and an adaptor for connection to a power supply. The instrument is 
commonly used for patients with rheumatic diseases and has been tested for validity and 
 
  30 
reliability for patients with RA 57 9 68. Grippit has not been validated for patients with total 
elbow arthroplasty (Appendix III).  
A Patient Global Assessment (PGA) of elbow function were also included, which is a one 
item question on a 5 point categorical scale ranging from 1 to 5 (5 equals bad function) 
(Appendix IIII).  
For analytical purposes, the sum scores of the Quick-DASH, MEPS and ASES were all 
transformed, with 0 representing worst possible score and 100 representing best possible 
score.  
Table 1: Measurement characteristics of the different outcome measures used in this study based on 
types of assessment and conceptual framework 
TYPE OF 
ASSESSMENT 
ICF HRQOL  
 
Outcome 
measure, 
instrument/tes
t 
Patient 
assessed 
Clinical 
assessed 
Body 
function 
and 
structures 
Activity Participatio
n 
Functional 
status 
Subjectiv
e 
wellbeing 
 
Quick-DASH 
 
X 
  
X 
 
X 
 
X 
 
X 
 
X 
ASES func. X X X X  X X 
ASES pain X  X X  X X 
ASES sat. X   X   X 
MEPS  X X X  X X 
PGA X   X  X X 
ROM  X X   X  
Grippit  X X   X  
Quick-DASH: Short version of the Disabilities of Arm, Shoulder and Hand function  
ASES: American Shoulder and Elbow Score, function, pain and satisfaction 
MEPS: Mayo Elbow Performance Score 
PGA: patient global assessment 
ROM: range of motion 
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5. Extended results 
5.1 Characteristics of the study population  
Total elbow arthroplasty is a surgical intervention often used as a last treatment option in the 
prevention of permanent disability for elbow joint destruction, mostly seen in RA. There are 
many studies in the scientific literature of the mid- and long-term results after elbow 
arthroplasty. However, most of these are based on clinical assessed outcome measures, only 
few studies have used standardized, valid and comprehensive assessments.  Few studies have 
examined the comparability of the various instruments used, in relation to their relative 
psychometric properties. Table 2 shows the results of some comparable populations of 
studies that have employed the same outcome measures used in the present study.   
The comparison shows that our population is somewhat older in mean age than the other 
populations presented in the table. The studies have about the same amount of participants 
(N), but some have more 4;44 and some have less 45 34 patients included in their studies. The 
table illustrate that the different studies use different ways to measure outcome. Range of 
motion (ROM) is one of the measures most widely used.  Figure 4 shows that our population 
has approximately the same mean ROM arc in flexion and extension compared to the other 
studies. Some studies report that their population had an arc over 100 ° 17 4 while other 
studies including the present study 78 40 have an arc below 100 ° (Fig. 4). When viewing 
other outcome measures our study has a lower mean score in the patient-assessed Quick-
DASH compared to the similar DASH score 4. On the other hand, our population reports less 
pain (ASES pain), but they are less satisfied (ASES satisfaction) with the surgery and do not 
experience as good function. When comparing the MEPS score, which is a clinical assessed 
sum score for pain and function, our population do not perform as well as the other studies in 
using MEPS as an outcome measure (Table 2).  
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Table 2: Studies viewing total elbow arthroplasty using some of the same outcome measure, the most 
relevant publications also used in figure 4 and 5 are presented in bold letters.  
Authors, 
public. year 
Design N = 
participants 
(elbows) 
Mean 
age 
(yrs) 
Diagnosis, 
(beside from 
TEA) 
Outcome measure (sum score mean, 
100 best health, ROM flex.ext.) 
     
Retrospective, follow-up 
35.4 mnts 
15 (16) 56 Verstreken et 
al. 1998 72 
RA 
 
MEPS: 89.3 
de Boer et al 
1999 18 
Cross-sectional 
 
42 60 RA, not all with 
TEA 
MEPS: 78  ROM: 106 ° 
Yanni et al. 
2000 78 
Retrospective, follow-up 
6.4 yrs 
49  RA MEPS: 88.4  ROM: 93.2 ° 
Pre/post- follow-up 16 yrs   RA MEPS: 81/77 Tanaka et al. 
2001 67 
Retrospective, follow up 
39.4 months 
7 55.5 RA MEPS: 93.1 ROM: 101.3 ° Lee et al 2005 
45 
Pre/post, follow-up 82 
months 
47 57 RA ROM: 88 ° Khatri et al. 
2005 40 
Angst el al. 
2005 (Angst et 
al. 73-82) 
Retrospective, cross-
sectional, follow-up 6-19 
yrs (assessment of clinical 
outcome 
79 64.1 RAPost-
traumatic 
Osteoarthritis  
SF-36: 57.4 DASH: 55.3 PREE: 66.8 
ASES function: 75.6 ASES pain: 71.2 
,ASES satisfaction: 81 ROM: 107 ° 
Retrospective, follow-up 
10-31 yrs 
40 56 Degenerative 
elbow 
MEPS: 91 Aldridge et al. 
2006 1 
Landor et al 
2006 44 
Pre/post- follow up 9.5 yrs. 58 (49)  RA MEPS: 30/ 82 
Pre/post, follow-up 5 yrs. 16 (20) 64 RA, PtOa MEPS: 78/90, Satisfaction: 86 Hildebrand et 
al 2006 
(Hildebrand et 
al. 1379-86) 
Cesar et al. 
2007 14 
Retrospective, follow-up 
74 months 
34 (44) 55.7 RA MEPS: 87.5 
Torskog et al 
2009 
Retrospective, follow up  32 68.5 RA  Quick-DASH: 47.2, ASES pain:77, 
ASES sat: 69.4, ASES function: 52.3, 
MEPS 62.8, ROM: 97.6° , Grip-
strength: 67.9 Newton 
Quick-DASH: Short version of the Disabilities of Arm, Shoulder and Hand function  
PREE: Patient-rated Elbow Evaluation 
ASES: American Shoulder and Elbow Score, function, pain and satisfaction, pain, satisfaction, function 
MEPS: Mayo Elbow Performance Score 
ROM: range of motion 
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Figure 4: Comparison of ROM (flexion-extension arc) of the different populations in other studies 
dealing with  total elbow arthroplasty presented in table 2.  
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Figure 5: Comparison of the different outcome measures in other studies presented in table 2 using the 
same instruments when dealing with total elbow arthroplasty  
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5.2 Performance of the instruments  
5.2.1 The content validity of the Quick-DASH 
Based on the impact of the elbow joint for the total arm function, the Quick-DASH was 
considered as a gold standard among the instruments measuring elbow function in this study. 
It is therefore important not only to take the sum score of the Quick-DASH into account, but 
also how each item is assessed and distributed by the participants. Normal distributions are 
positive properties of a scale, and allow using sensitive parametric significance tests. Low 
ceiling and floor effects allow differentiating between the patients by the score 5. When 
scores “top out” and the item or instrument cannot register greater gains, this term is called 
ceiling effect, when scores “bottom out” and the item or instrument cannot register greater 
declines, this is termed floor effect 19.  
The sum score of the quick-DASH was normally distributed (Fig. 6), but some of items 
disclose what the participants experience as most or least difficult, also expressed as floor or 
ceiling effects. Grip force activities (open jar and recreational activities) showed floor effect 
(more than 15% of the participants reported worst possible score 60), whereas the “social 
participation/involvement” item showed ceiling effect (Fig. 7). 
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Figure 6: Histogram of the sum score of Quick-DASH for this 
population (n=30), mean (SD) 47.2 (20.2) 
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Ceiling effects/ difficult activities Floor effect/not difficult activities
Open tight/ new jar, ceiling effect, 
mean (SD) 4.2 (1) 46.9 % 
Recreational activities with use of 
arm/shoulder/ hand, ceiling effect, 
mean (SD) 4 (1.1) 40.6% 
Interference of arm/ shoulder/ hand 
with normal social activities? floor 
effect, mean (SD) 2.2 (1.1) 43.8 % 
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Figure 7: Single item presentation of the floor and ceiling effects of the Quick-DASH (1-5, 5 worst possible score) n= 30 
 
 
5.2.2 Discrimintive ability of the outcome measures 
In order to evaluate the instruments ability to discriminate between patients who report to 
have good function compared with those reporting moderate/ bad function, the total group of  
participants was split into two groups based on their own reported assessment of the elbow 
function after the total elbow arthroplasty.   
The group was dichotomized to good function (very good, good) and moderate/bad function 
(middle, bad, and very bad). The mean score of the different variables were compared using 
the Students independent-samples t-test 60. 
The ASES function ASES pain scores showed a statistically significant difference between 
The group that reported good function and those who reported moderate/bad function 
(p<0.05). Grip strength did not discriminate between the groups, showing low grip strength 
for nearly all patients. ROM between the two groups show a statistical relevant difference 
between the groups (p= .011), those who report good function have an arc over 100 ° while 
those who report moderate/bad function have an arc below 100 °. Having a flexion-extension 
arc of more than 100 ° have previously in the paper been described as what is needed to have 
 
  36 
a functional elbow. This might indicate that patients who report to have a functional elbow 
of more than 100 ° report to have a good functioning total elbow arthroplasty.  
 
 
 
Table 3: Students independent samples t-test, comparing those who report good function with those who 
report moderate/bad function 
Instruments/ tools Good function 
Mean (SD) 
Moderate/bad function 
Mean (SD) 
p-value SMD¹ 
 
Quick-DASH  
(0-100, 100 best) 
 
53 (21.7) 
N= 17 
 
40 (15.9) 
N= 13 
 
.082 
 
0.69 
MEPS 
(0-100, 100 best) 
68.1 (21.5) 
N= 17 
55.8 (15.2) 
N= 13 
.092 0.67 
ASES function 
(0-100, 100 best) 
62 (29.2) 
N= 17) 
40.5 (26.8) 
N= 14 
.043 0.77 
ASES pain 
(0-100, 100 best) 
88.4 (16.7) 
N= 18 
61.1 (17.3) 
N= 13 
.000 0.04 
Grippit (Newton) 54 N (31.1)  
N= 16 
57 N (72.6) 
N= 12 
.876 0.06 
ROM (degrees °) 105 ° (9.7))  
N= 18 
87 ° (26) ) 
N= 14 
.011 1.008 
¹ Standardized Mean Difference, effect size for group difference 
Quick-DASH: Short version of the Disabilities of Arm, Shoulder and Hand function  
ASES: American Shoulder and Elbow Score, function, pain and satisfaction, pain, satisfaction, function 
MEPS: Mayo Elbow Performance Score 
ROM: range of motion 
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5.2.3 Inter-tester reliability  
Inter-rater reliability is considered good if the scores of the different raters are equal when 
performing the same test at the same time. It is important both in clinical practice and in 
research that the test is reliable when performed by different raters. An important factor is 
therefore that the description on how to perform the test and how to score the assessment is 
precise 19. It is also of importance that the clinicians are trained on how to perform the 
different tests and that the patients are given a clear and standardized explanation on how to 
perform or assess the questionnaires (ibid).  
Range of motion is, as described earlier, one of the clinical tests mostly used in evaluation of 
total elbow arthroplasty. In this study, a surgeon and a physiotherapist measured the range of 
motion of the elbow subsequently.  
The results of the inter-rater tests were visualised by Bland Altman plots. The Bland Altman 
method is a statistical method to compare two measurement techniques or raters. The 
graphical method displays the differences between two raters plotted against the averages of 
their scores 11.  
In Fig. 8, the agreement between the surgeon and the physiotherapist was examined 
graphically by plotting the differences between the two raters (y-axis) against the mean of 
their scores (x-axis). The limits of agreement were calculated as the mean difference 
between the raters ± 1.96 SD of the difference.  
The smallest detectable difference (SDD) was calculated as the mean difference multiplied 
with 1.96 SD of the mean score, and reflects the inaccuracy of the goniometric measuring 
method in this patient group. The margin of error was nearly 30 º for flexion, for extension 
12 º and for pronation / supination arc as much as 57 º.  This means that when estimating 
change in elbow flexion for example, the result must exceed 30 º to be regarded as a real 
change (more than the error of the method).  
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Table 4: Inter-tester reliability: range of motion (ROM) measurements of the elbow between to 
testers (surgeon and physiotherapist) 
ROM elbow Surgeon 
mean ° (SD) 
Physiotherapist 
mean ° (SD) 
LOA¹ SDD² 
flexion 135.2 (12) 131.1 (18.5 ) 33.1, -24.95 29 
extension -34.4 (16.7 ) -35 (15.8 ) 12.4, -13 12.4 
flex/ext arc 98.6 (20.5 ) 95.6 (21.1 ) 12.3, -18.3 15.3 
pronation 60.9  (28.1 ) 68.8  (29.5 ) 50.5, -34.9 42.7 
supination 64.1 (30.5 ) 58.7  (28.4 ) 30, -40.6 35 
pro/sup arc 124.7 (49.4 ) 127.5  (52.1 ) 59.8, -54.2 57 
¹Limits of agreement (mean difference between the raters ± 1.96 SD of the difference)  
²Smallest Detectable Difference (mean difference between testers) x (1.96 x SD mean diff) 
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Figure 8: Bland Altman plots of the ROM measurements of the two testers, y-axis: the difference 
between the two testers, x-axis: the mean difference between the two testers. The line in the middle is the 
mean difference between the two testers, and the two other lines represent the limits of agreement 
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6. Main findings 
• Grip strength, range of motion and performance of some daily activities were 
significantly impaired 1- 5 years after surgery in patients with elbow arthroplasty  
• The patients reported moderate level of pain and more than half of them evaluated 
their elbow function as good or very good 
• When compared to age-and gender-matched healthy controls, the participants had 
approximately a fourth of the normal grip strength. This limitation was also reflected 
in patient assessed measures of activities requiring grip strength, as many of the 
patients reported worst possible scores on items like opening a tight/new jar, and 
playing golf or tennis 
• Only about half of the patients in this study had a flexion/extension arc equivalent to 
or exceeding 100°, which is considered the minimum ROM required for acceptable 
elbow function, indicating that they experience difficulties in performing daily 
activities 
• It is important to be aware that even if patients report low level of pain, satisfactory 
level of functioning and high satisfaction with the arthroplasty, there might still be a 
considerable potential for improvement in specific functions and activities 
  
• The Quick-DASH provides an important supplement and reveals important 
functional disabilities, such as lack of grip strength. Significant correlations with 
Quick-DASH were found for all measures except for range of motion. Patient 
assessed instruments supplement, but do not replace clinical assessed measurements 
such as ROM and grip-strength  
• When measuring range of elbow motion, a considerable margin of error must be 
taken into account  
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• The results of this study support the need of both clinical- and patient assessed 
measures for optimal evaluation and management of patients with total elbow 
arthroplasty   
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Article 
Pain and function in patients with rheumatic disease and elbow 
arthroplasty: clinical and methodological aspects 
Caroline Torskog, Tarjei Lona, Terje Ugland, Kari Eikvar, Hanne Dagfinrud 
Background 
Rheumatoid arthritis (RA) is the most frequent inflammatory rheumatic disease, with a 
prevalence of 0.5-1.0 % in the adult population in western countries 10. It is a chronic  
disease, resulting in joint swelling, tenderness, pain and stiffness, and may cause various 
degree of joint destruction 23. 
It is reported that 20-50 % of RA patients show clinical and radiological evidence of elbow 
joint involvement 1;22. Normal elbow function is required for positioning the hand in space, 
which is crucial in the performance of activities of daily living, e.g., reaching the hand to the 
mouth. Loss of elbow function therefore may cause severe activity limitations, and is 
considered more disabling than loss of shoulder or wrist function 14.   
Non-surgical treatment is the first choice in patients with elbow joint involvement, including 
oral analgesics, intra-articular steroid injections, physical therapy and splinting. If 
conservative treatment no longer provides relief, total elbow arthroplasty is considered an 
important treatment option. Patients with RA frequently experience multiple joint 
involvements, and the total arm function, including shoulder and hand joints, must therefore 
be considered when deciding upon what is the most optimal treatment.  
Joint replacement may provide a satisfactory result for patients with severe elbow joint 
destruction. However, due to factors related to survival of the prosthesis, patient's age and 
expected activity level must also be taken into consideration 22. Studies providing results 
after elbow arthroplasty are mainly based on clinical assessment of impairment, mostly 
presented as range of motion (ROM). Only a few studies have evaluated the result of elbow 
arthroplasty using standardized, valid and comprehensive instruments and methods 1;11;20. 
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Although a variety of scores exists, few of the patient- and clinical assessed instruments 
available for evaluating the functional and clinical state of the elbow have been validated for 
measuring outcomes of elbow arthroplasty 21. As loss of elbow function may influence 
health related domains on impairment level as well as on activity and participation level, 
tests and instruments used for monitoring and evaluating the result of elbow arthroplasty 
ideally should cover all these domains 25.   
In a cross sectional follow-up examination 1-5 years after total elbow arthroplasty in patients 
operated at Diakonhjemmet Hospital, several frequently used methods and instruments for 
measuring elbow function were applied concurrently. The aims of this comprehensive 
examination was to describe the level of pain and function in patients with elbow 
arthroplasty, and to evaluate psychometric properties of clinical- and patient assessed 
instruments for evaluation of elbow function after total elbow arthroplasty.   
Material and methods 
As part of a routine postoperative examination of patients with total elbow arthroplasty 
operated at Diakonhjemmet hospital during the last 5 years (2002-2007), we developed a 
protocol for evaluating the properties of the most commonly used clinical- and patient 
assessed instruments for elbow function after a total elbow arthroplasty.  
Patients 18 years or older with uni- or bilateral elbow prostheses, (primary or revision 
surgery), were considered for the study. All patients met for follow-up in the same short time 
period, independent of time since last surgery.  Patients were excluded if they had a 
malignant disease, alcoholism, serious mental problems or cognitive impairment.  
According to standard follow-up routines, the examination of the elbow joint comprised 
ROM, grip strength, pain and patient assessed functioning. The clinical tests were performed 
by a surgeon and a physiotherapist and the patients answered two standardised 
questionnaires.  
Normative data for grip strength, ROM and DASH score were drawn from relevant 
publications 1;12;15.  
 
Patient assessed instrument 
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The shortened disability of the Arm, Shoulder and Hand questionnaire (Quick-DASH) is 
shortened version of the disability of the Arm, Shoulder and Hand questionnaire (DASH), 
and is a patient assessed questionnaire containing 2 items addressing pain, 8 items 
concerning function and one addressing sleep quality in persons with any or multiple 
musculoskeletal disorders of the upper limp. Items are not attributed to the affected limb, but 
focus on the individual's ability to perform activities regardless of which arm, shoulder or 
hand they use. Patients self-report function on a 5- point categorical scale, from "no 
difficulty" to "unable to do". The scores for all items are used to calculate a total score 
ranging from 0 (no disability) to 100 (severe disability) 2.  
The full length DASH is validated for upper extremity complaints in patients with RA 18. 
Studies have demonstrated that the DASH can be replaced with the Quick-DASH 2;2;6 
A patient global assessment score was also included, where the patients rated their total 
elbow function on a 5-point categorical scale ranging from 1 to 5 (5 equals worst function). 
 
Combined patient- and clinical assessed instruments 
The American Shoulder and Elbow Surgeons Elbow assessment form (ASES) is a 
standardized elbow evaluation form including both a patient evaluation and a clinical 
assessment of elbow function. The ASES patient assessment has three subscales; pain, 
function and satisfaction 9. The pain scale contains 5 questions in which pain in the elbow-
region is rated on a 10 point categorical scale (10 equals worst pain ever), and a body-figure 
where the patient is asked to mark the location of the pain. The function scale consists of 10 
items asking patients to rate performance of daily activities on a 0 to 3 categorical scale. 
ASES also includes a single item where the patient is asked to rate their satisfaction with 
surgery on a 0-10 scale (10 = very satisfied) 9. The clinician assessed part contains 
evaluation of joint motion, recorded with the use of a goniometer. The ASES also includes 
evaluation of elbow joint stability and muscle strength, but these scales were not used in this 
study.   
Weighting of the various subscales and a standardised computations of a sum scale of ASES 
have not been reported 11. In this study, three sum scores were calculated; for pain, for 
function (including the patient- and the clinical assessments of total elbow function), and for 
satisfaction.  
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Mayo Elbow Performance Score (MEPS) is a clinician rated assessment of pain, range of 
motion, stability and function on 0-100 scale (100 best score) 13. Standard terminology and 
information considering how each item should be rated is lacking. The response items are 
dichotomous (present/ or absent) and the instrument is therefore less able to discriminate 
between different levels of functional disability13. Even if MEPS is a widely used outcome 
measure, the knowledge of the instruments psychometric properties is scarce 4;20. 
Clinical assessed measures 
Grip strength was measured with the Grippit instrument.  Grippit measure the maximum 
momentary force and the mean force over a set period of time (10 seconds). The instrument 
consists of a grip device, an electronic unit and an adaptor for connection to a power supply. 
Grippit is commonly used for patients with rheumatic diseases and has been tested for 
psychometric properties for patients with RA, but has not been validated for patients with 
total elbow arthroplasty 3;15;24. 
Statistical analysis 
The socio-demographic and clinical variables were presented as mean and standard 
deviation (SD) for continuous variables whereas frequencies (percentage) were calculated 
for categorical variables. Clinical measures (ROM and grip strength) were visualised with 
scatter-plots and compared with age and gender matched population based scores.  
In order to explore level of function in different activities, the single items of the Quick-
DASH were presented with minimum and maximum scores. We also examined possible 
floor and ceiling effects, and considered these as present if more than 15% of the 
respondents achieved lowest or highest possible score, respectively. Internal consistency 
(how well a set of items measures a uni-dimensional construct) was tested by Cronbach’s 
alpha coefficient and calculated for all measures, except from the MEPS, due to the mix of 
assessment methods within this measure. A Cronbach’s alpha >0.70 was considered 
acceptable 17. 
Correlations between measures were examined by Pearson correlation coefficient (r), and the 
coefficients of determination were used to calculate shared variance between the different 
scores and the Quick-DASH. As all assessments measure elbow function, we hypothesized 
that the correlation coefficients between the scores would be high (r ≥0.7). The Quick-
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DASH was regarded as closest to a gold standard and was used as dependent variable in a 
multiple regression analysis.  
For comparison, all scales were transformed to 0-100, 100 representing best function.  
For statistical analysis, Statistical Program for Social Services, version 15.0, SPSS Inc., 
Chicago, USA (SPSS for Windows (version 16.0)) was used. P-values below 0.05 were 
considered to be significant. 
Results 
Thirty two patients were included in this study, 24 women and 8 men, mean age 68.5 min-
max years.  Mean (SD) duration of the current arthroplasty was 3.1 (1.2) years. The 
arthroplasty was revised one or more times in 56 % of the patients. Twenty-four participants 
had RA; the other participants had other rheumatic diseases or posttraumatic arthritis.  
The patients reported moderate level of pain (mean (SD) 77 (22)), while the mean (SD) 
upper arm function was 47 (20) for the Quick-DASH. Further, the mean (SD) satisfaction 
score was 69 (25), with 56% of the patients rating their elbow function as good or very good 
(Table 1a,1b). 
The mean (SD) flexion/extension arc was 97.6 ° (21.4) (compared to 140 ° in a healthy 
population) and the mean (SD) maximal grip strength was 118 (93) N for men and 54 (33) N 
for women (compared to 430 N and 220 N, respectively in healthy men and women), 
indicating impaired function concerning both range of motion and grip strength (Fig 1-2).  
The sum score of the quick-DASH was normally distributed, but single items showed ceiling 
effects for grip strength activities (open jar and recreational activities) and floor effects for 
the item addressing interference of arm function with normal social activities (47 % and 44 
% respectively) (Table 1a). The internal consistency of the Quick -DASH scores were 
acceptable (Cronbach's alpha coefficient 0.90) (Table 1a).  
In a multivariate regression model, grip strength contributed significantly (p= 0.03), while 
ROM did not contribute to the variation (p=0.81) of the Quick-DASH score. Due to the well 
known difference in grip strength between men and women, the multivariate analysis was 
performed for men and women separately, and reported in details only for women (Table 2). 
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Neither grip strength nor ROM contributed significantly for men, but the results should be 
interpreted with caution, due to the small sample size.  
Significant correlations with Quick-DASH were found for all measures (p<0.01), except for 
ROM (r= 0.2, p=0.35). ROM explained 3% of the variance in the patient assessed function 
score, while grip strength explained 29 %.   
Discussion 
 
Clinical evaluation 
This comprehensive evaluation of patients with elbow arthroplasty showed that grip 
strength, range of motion and performance of daily activities were significantly impaired 1- 
5 years after surgery. However, the patients reported moderate level of pain and more than 
half of them evaluated their elbow function as good or very good.  
 
When compared to age-and gender-matched healthy controls, the participants in this study 
had approximately a fourth of the normal grip strength. It is well known that RA patients 
suffer from impaired hand function. In a Swedish study, the Grippit scores for women with 
RA were barely higher than in our joint replacement cohort 15. Limited grip strength is 
expected in patients with established RA, and it is important to notice that elbow joint 
replacement does not seem to improve hand function. The limited grip force was also 
reflected in patient assessed measures of activities, as many of the patients reported worst 
possible scores on items requiring good hand function, like opening a tight/new jar, and 
playing golf or tennis. The strong influence of grip strength on daily activities was further 
confirmed in a regression model, showing that grip strength was more important than range 
of motion in explaining the variation of the Quick-DASH score. These results are in 
concordance with another study, in which grip force was found to be the strongest regressor 
of activity limitations 24. For optimal rehabilitation of patients with elbow joint involvement, 
an enhanced focus on muscle strength may be recommended.  
 
In this study, only 17 of the patients had a ROM equivalent to or exceeding 100° , which is 
considered the minimum ROM required for acceptable elbow function 16 12 . These results, 
as well as the scores from the functional scales, confirm that many of the participants 
experience difficulties in performing daily activities. However, despite these physical 
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limitations, patients reported to be fairly satisfied with the result of their elbow arthroplasty. 
Further, patients reported the interference of the elbow affection with social activities to be 
surprisingly low. This is in contrast with results of other studies, in which of persons with 
RA report that they often experience restrictions in participation and social roles 5 19. One 
reason for these differences may be that the elbow arthroplasty was performed in a later 
disease stage in our participants, and that they have during a long-term disease course 
learned to compensate for the loss of specific functions by developing adaptive strategies.  
 
Evaluation of instruments 
Validity is an elusive concept measured by a variety of methods. In this study a construct 
validation process was applied, by comparing measures designed to assess the same concept 
of function. The included measures of function showed similar properties, but Quick-DASH 
also provided important information by revealing limited hand function.  
 
Significant floor effects were found for single items of the Quick-Dash involving grip-
strength. In accordance with this finding, significant correlation was also found between the 
Quick-DASH and grip-strength (p<0.004). Thus, there seem to be a strong association 
between grip strength and elbow function, and examination of grip strength should therefore 
be part of a complete assessment of the results of elbow arthroplasty. In contrast, the 
association between the Quick-DASH and ROM scores was weak (p=0.35), indicating that 
limited elbow motion has less impact on activity performance compared to the impact of 
reduced grip strength. This was also confirmed in a multiple regression model with the 
Quick- DASH as dependent variable.  
 
All the patient-assessed measures included in this study comprise a combination of items 
addressing pain and function. Still, the mean Quick-DASH sum score was lower (worse 
function) than the other scores. This is probably due to unequal weighting of function and 
pain in the different studies, underlining that pain and function are two different concepts, 
even if they are correlated 1 21. Pain is regarded as the most important factor affecting health 
perception. It is therefore not surprising that patients' report to be satisfied with the operation 
based on their perceived pain reduction 7. However, in order to optimise the benefit of the 
intervention, patients' assessment of general function and specific joint function should also 
be included when the outcome is evaluated.  
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The concurrent use of both clinical- and patient assessed measures allow for a comparison of 
the different perspectives of patients and health professionals. The discrepancy in the scores 
derived from clinical- and patient assessed measures demonstrated in this study is supported 
in other studies and is a well known phenomenon in chronic diseases 1 21. It is important to 
be aware that even if patients report low level of pain, satisfactory level of functioning and 
high satisfaction with the arthroplasty, there might still be a considerable potential for 
improvement in specific functions and activities.  
 
A limitation of this study is the uncontrolled, cross-sectional design. Longitudinal studies are 
required to monitor disease course and to examine the responsiveness of the outcome 
measures.   However, the comprehensive examination performed in this study allowed for a 
thorough description of function in patients with elbow arthroplasty.  
 
It has been shown that patients' view does not necessarily correlate with clinical data, and   
studies relying on only clinical measures may therefore be in risk of underestimating the 
high level of  satisfaction among the patients, which may be decisive in determining future 
utilization of health care resources 1;8. On the other hand, only to use patient assessed 
measures may lead to an over-optimistic evaluation of the functional outcome, with the risk 
of not utilising the true potential for improvement. To ensure optimal evaluation and 
management of patients with total elbow arthroplasty, one should therefore use both clinical- 
and patient reported measures. 
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Table 1a: Patient assessed outcome measures for 32 patients with total elbow arthroplasty 
Instrument/ measures Median Min/ max 
Patient assessment Quick-DASH single items (1-5, 5 worst possible score)   
• Open tight/ new jar* 4.5 2-5 
• Heavy household cores 4 1-5 
• Carry bag/ briefcase 3 1-5 
• Wash back 4 1-5 
• Use knife/ cut food                                 3 1-5 
• Recreational activities with use of 
arm/shoulder/ hand* 
4 1-5 
• Interference of arm/ shoulder/ hand with 
normal social activities (last week)** 
2 1-5 
• Limited in work/ other regular ADL as a result 
of arm/ shoulder/ hand (last week) 
3 1-5 
• Arm, shoulder or hand pain 3 1-4 
• Tingling in arm/shoulder/ hand 3 1-4 
• Sleeping difficulties because of arm/ shoulder/ 
hand (last week) 
 
2 1-4 
Patient assessment sum score (0-100, 100 best health) Median/ mean 
(SD) 
Min/ max Cronbach's 
alpha 
Quick-DASH 47.7 / 47.2 
(19.7) 
14-97 0.90 
ASES pain  80 / 77 (21.6) 28-100 0.88 
ASES satisfaction 65 / 69.4 (25.4) 20-100  
Patient Global Assessment of elbow function (1-5, 5 
very bad function)  
2 / 2.4 (0.9) 1-4  
Patient- and clinical assessment combined sum score (0-100, 100 best health) 
ASES function 61.2/52.3 (29.7) 0-100 0.94 
MEPS total  62.2/62.8 (19.7) 34-100  
*Ceiling effect : open tight/ new jar 46.9 %, recreational activities with use of arm/shoulder/ hand 40.6% 
**Floor effect: interference of arm/ shoulder/ hand with normal social activities? 43.8 % 
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Table 1b: Clinical assessed outcome measures for 32 patients with total elbow arthroplasty 
Clinical assessment Mean (SD) Min/ max 
ROM flex/ext arc ° 97.6  (21.4) 30-135  
Grippit max  (N) 67.9  (56.4) 8-293  
Grippit mean (N) 55.1  (51.8) 5-276  
Quick-DASH: Short version of the Disabilities of Arm, Shoulder and Hand function  
ASES: American Shoulder and Elbow Score, function, pain, satisfaction, function 
MEPS: Mayo Elbow Performance Score 
ROM: range of motion 
°: degrees of flexion/ extension arc 
N: Newton 
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Figure 1: Scatter plot mean (SD) ROM (flexion and extension) for the elbow population. The dotted line 
shows range for functional elbow (100°) 
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Figure 2: Maximal grip strength (Newton) for men (118) and women (54) with elbow arthroplasty 
(straight lines) normal grip strength for men (432) and women (222) (dotted lines) 
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Table 2: Correlations and multivariate regressions of the patient-and clinical assessed instruments  
Correlations (Pearsons r) Multivariate regressions 
Instruments/ 
measurements 
Quick-DASH 
 
p-values  ß (CI) p-values 
ASES function 
 
.797 ≤ .0001 Age -.20 (-.65,.23) .34 
ASES pain 
 
.479 ≤ .0001 Grip strength .21 (.03, .39) .03 
MEPS 
 
.811 .009 ROM (flexion-
extension) 
.034 (-.25, .32) .81 
Grip strength 
 
.541 .004 
ROM (flexion-
extension) 
.178 .348 
 
Quick-DASH: Short version of the Disabilities of Arm, Shoulder and Hand function  
ASES: American Shoulder and Elbow Score  
MEPS: Mayo Elbow Performance Score 
ROM: range of motion 
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Appendix 
I: The Quick-DASH 
II: The Mayo Elbow Performance Score (MEPS) 
III: The American Shoulder and Elbow Surgeon assessment form (ASES) 
IIII: Patient Global Assessment of total elbow function 
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Appendix I 
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Appendix II 
The Mayo Elbow Performance Score 0-100, 100 best (MEPS) 
Funksjon Poeng Definisjon (poeng) 
Smerte 45 Ingen (45) 
Mild (30) 
Moderat (15) 
Alvorlig (0) 
Bevegelighet   20 >100 ° (20) 
50-100 ° (15) 
<50 ° (5) 
Stabilitet  10 Stabil (10) 
Moderat instabilitet (5) 
Stor instabilitet (0) 
Funksjon   25 Gre hår (5) 
Spise selv (5)  
Utføre hygiene (5) 
Kneppe skjorte (5) 
Snøre sko (5) 
Totalt   100  
Classification: Excellent >90, Good 75-89, Fair 60-74, Poor <60 52 
 
 
 
 
 
 
  66 
Appendix III 
American Shoulder and Elbow Surgeons assessment form (ASES) 
Dato:  Id. nr: 
Alder:  
Diagnose:  
Dominant hånd: 
Kjønn: 
Opr. albu:  
Opr. dato: 
 
ASES Pasient rapportert smerte 
 
 
Har du smerter i albuen? (kryss av) 
 
 
 JA 
 
 NEI 
 
Markèr på figuren under hvor du har smerter: 
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ASES pasient rapportert smerte 
HVOR STERK ER SMERTEN I ALBUEN DIN? 
(sett ring rundt det tallet som stemmer mest med din smerte) 
NÅR SMERTEN ER PÅ SITT ALLER VERSTE 
                               0       1       2       3       4       5       6       7       8       9       10 
  |-----------------------------------------------------------------------------| 
 Ingen smerte                                                                       Verst tenkelige smerte 
NÅR ARMEN ER I RO 
                                 0       1       2       3       4       5       6       7       8       9       10 
  |-----------------------------------------------------------------------------| 
 Ingen smerte                                                                       Verst tenkelige smerte 
NÅR DU LØFTER EN TUNG GJENSTAND 
                                0       1       2       3       4       5       6       7       8       9       10 
  |-----------------------------------------------------------------------------| 
 Ingen smerte                                                                       Verst tenkelige smerte 
 NÅR DU MÅ BØYE ALBUEN MANGE GANGER ETTER HVERANDRE 
                               0       1       2       3       4       5       6       7       8       9       10 
  |-----------------------------------------------------------------------------| 
 Ingen smerte                                                                       Verst tenkelige smerte 
OM NATTEN 
                               0       1       2       3       4       5       6       7       8       9       10 
  |-----------------------------------------------------------------------------| 
 Ingen smerte                                                                       Verst tenkelige smerte 
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ASES Pasient rapportert funksjon 
Sett ring rundt det tallet som passer best 
0 = Ikke i stand til det    1 = veldig vanskelig     2 = litt vanskelig         3 = ikke vanskelig 
 Høyre Venstre 
Kneppe skjorte / bluse helt opp 0        1        2        3 0        1        2        3 
Gå på toalettet 0        1        2        3 0        1        2        3 
Gre håret 0        1        2        3 0        1        2        3 
Knytte skoene 0        1        2        3 0        1        2        3 
Spise (bruke kniv og gaffel) 0        1        2        3 0        1        2        3 
Bære en tung gjenstand 0        1        2        3 0        1        2        3 
Reise deg fra stol ved å skyve fra med armene 0        1        2        3 0        1        2        3 
Utføre tungt husarbeid 0        1        2        3 0        1        2        3 
Vri om en nøkkel 0        1        2        3 0        1        2        3 
Kaste en ball 0        1        2        3 0        1        2        3 
Utføre ditt vanlig arbeid 0        1        2        3 0        1        2        3 
Gjøre sports-/ fritidsaktiviteter 0        1        2        3 0        1        2        3 
 
 
Pasient rapportert tilfredshet 
Hvor tilfreds er du med albuproteseoperasjonen?  (Sett ring rundt det tallet som du synes passer best) 
   0        1          2         3         4         5        6       7        8          9         10 
   |------------------------------------------------------------------------------------|  
                          Ikke tilfreds i det hele tatt                                           
Veldig tilfreds 
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Klinisk vurdering  
BEVEGELIGHET 
Aktive bevegelsesutslag (grader) Høyre Venstre 
FLEKSJON   
EKSTENSJON   
FLEKSJON + EKSTENSJON (arc)   
PRONASJON   
SUPINASJON   
PRONASJON + SUPINASJON (arc)   
 
STABILITET 
0 = ingen instabilitet 1 = lett instabilitet med normalt stoppfølelse 2 = moderat instabilitet uten 
stoppfølelse 3 = stor instabilitet 
INSTABILITET HØYRE VENSTRE 
Valgus 0     1     2     3 0     1     2     3 
 
Varus 0     1     2     3 
 
0     1     2     3 
 
Posterolateral rotasjon 0     1     2     3 
 
0     1     2     3 
 
 
STYRKE 
 0 = ingen kontraksjon 1 = antydning til kontraksjon 2 = bevegelse med tyngdekraften eliminert 3 = 
bevegelse mot tyngdekraften 4= bevegelse med noe motstand 5 = bevegelse med normal kraft 
Blir testen påvirket av smerte? ja/nei HØYRE VENSTRE 
Fleksjon   
Ekstensjon   
Pronasjon   
Supinasjon  
Gripe styrke- Grippit (Newton) 
Hø: max:                      gj.snitt:  
Ve: max:                      gj.snitt: 
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                                Patient Global Assessment of elbow function       Appendix IIII 
TOTALVURDERING AV ALBUEFUNKSJON 
 
Hvordan vil du alt i alt vurdere din albuefunksjon? 
                                                                                                                      
veldig god                  god                       middels                   dårlig                    veldig dårlig 
 
